Tech Company Financing Transactions
Kura Oncology Funding Round
Kura Oncology, based in San Diego, raised $60 million from EcoR1 Capital Management and private investors.
Transaction Overview
Company Name
Announced On
3/13/2015
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Undisclosed
Investors
EcoR1 Capital Management (Lead Investor)
Proceeds Purpose
We expect the proceeds from this financing will allow us to rapidly move forward with the clinical development of tipifarnib as well as advance our preclinical programs towards the clinic.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3033 Science Park Rd. 220
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
At Kura Oncology (NASDAQ: KURA), we are committed to realizing the promise of precision medicines for cancer. The genomics revolution is transforming how we treat cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Troy Wilson
Chief Financial Officer
Marc Grasso
Chief Operating Officer
Kathleen Ford
VP - Bus. Development
Kirsten Flowers
VP - Finance
Jackie Tran
VP - General Counsel
James Basta
VP - R & D
Francis Burrows
Browse more venture capital transactions:
Prev: 3/13/2015: Surveypal venture capital transaction
Next: 3/13/2015: Favor venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC transactions reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs